If you’re in your 40s and wondering whether your changing symptoms point to perimenopause, the Peri-SS is a 16-item symptom questionnaire built to measure how much symptom burden you’re carrying. It gives you a total on a 0 to 100 scale, based on how you rated each symptom over the past 30 days. Flo Health’s press release says its scientists built the scale with Mayo Clinic clinicians, and the validation study was published in Menopause, the journal of The Menopause Society. Here is what it asks, how it was tested, and how to use it when you talk with your gynecologist.
Disclosure: A number of the links on this page are affiliate links. The editors may earn a commission when you buy through these links. This costs you nothing extra.
Peri-SS quick facts, dated 2026-11-17
| Fact | Detail | Source |
|---|---|---|
| Full name | Perimenopause Symptom Scale (Peri-SS) | Flo Health press release, November 12, 2026 |
| Built by | Flo Health scientists with Mayo Clinic clinicians, according to the company | Flo Health press release |
| Published in | Menopause, the journal of The Menopause Society | Flo Health press release; Contemporary OB/GYN summary, November 12, 2026 |
| Length | 16 items in four areas | Contemporary OB/GYN summary |
| Time frame | Symptoms rated over the past 30 days | Flo Health press release |
| Score | Each item rated 0 to 4; total scaled 0 to 100 | Contemporary OB/GYN summary |
| Validation sample | 1,255 U.S. women aged 35 to 59, recruited through Prolific, February 27 to March 16, 2025 | Contemporary OB/GYN summary |
| Reliability (perimenopausal participants) | Cronbach alpha 0.90; test-retest ICC 0.82 (ICC from 552 participants) | Contemporary OB/GYN summary |
Who built the Peri-SS, and where was it published?
Flo Health’s Flo Health press release, dated November 12, 2026, says the scale was developed by Flo scientists in collaboration with Mayo Clinic clinicians. The release is the company speaking about its own product, so read it as Flo’s account. It also names Dr. Liudmila Zhaunova, Flo’s Director of Science, as one of the lead authors on the paper.
The paper is titled “Validation of the Perimenopause Symptom Scale (Peri-SS) for Digital Self-Assessment,” and it appeared in Menopause. You can read the paper at the Peri-SS validation study in Menopause. Contemporary OB/GYN also summarized the study in an article dated November 12, 2026, which is worth reading alongside the paper.
Key dates
- February 27 to March 16, 2025: the validation survey was run, with participants recruited through Prolific.
- November 12, 2026: Flo Health’s press release, and the date of Contemporary OB/GYN’s summary of the paper.
- November 13, 2026: the first episode of a Special Report on testosterone in women.
- November 16, 2026: Contemporary OB/GYN’s weekly review, which included that episode.
Who is the Peri-SS for?
The validation study included U.S. women aged 35 to 59, so it fits the age range of a woman in her 40s. Flo’s release describes perimenopause as “the time leading up to menopause when fluctuating hormone levels can lead to a variety of symptoms.” Its examples include mood and memory changes, hot flashes, sleep disruption and low sex drive.
What the 16 items ask about
The scale covers four areas. The item names below come from Flo’s release, and the area names and item counts come from Contemporary OB/GYN’s summary.
| Area | Number of items | What it covers |
|---|---|---|
| Vasomotor | 2 | Hot flashes, night sweats |
| Psychological and emotional stress | 5 | Anxiety, sleep difficulties, physical or mental exhaustion, feeling down or sad, irritability |
| Sexual health | 3 | Vaginal dryness, painful sex, low sex drive |
| Physical and somatic | 6 | Digestive issues, hair changes, skin changes, joint or muscle pains, bladder problems, weight changes |
The 16 items were narrowed from 25 that gynecologists proposed, using exploratory factor analysis in 948 self-reported perimenopausal U.S. women. Brain fog and headaches were dropped during development. Changes in your menstrual cycle sit outside the four scored areas.
How the Peri-SS scores your symptoms
You rate each of the 16 symptoms from 0 to 4, looking back over the past 30 days. Those ratings are combined into a total that is scaled from 0 to 100. In the validation study, the total fell when women’s Menopause Rating Scale scores improved and rose when those scores worsened. For the exact conversion, check the paper linked above.
Flo’s Dr. Zhaunova says the scale can help women “recognize patterns in their symptoms.” Flo’s release also says the Peri-SS is the basis for an in-app feature called the “Peri Score.”
How was the Peri-SS tested, and how reliable is it?
According to the paper as summarized by Contemporary OB/GYN, 1,255 U.S. women aged 35 to 59 were recruited through the Prolific research panel between February 27 and March 16, 2025. They completed the survey in English. Of these women, 633 identified as perimenopausal. Participants completed the Peri-SS, the Menopause Rating Scale (MRS) and the EQ-5D-5L at the start and again 7 to 14 days later.
| Measure | Reported result |
|---|---|
| Internal consistency (Cronbach alpha) | 0.90 overall, from 0.73 for vasomotor to 0.86 for psychological |
| Test-retest reliability (ICC) | 0.82 (95% CI 0.70 to 0.88) in 552 participants |
| Factor structure | Confirmatory factor analysis supported four areas: CFI 0.932, RMSEA 0.069 |
| Correlation with MRS total | r = 0.88 |
| Correlation with EQ-5D utility | rho = -0.50 |
| Change where MRS improved (n = 195) | Peri-SS fell a mean of 9.5 points |
| Change where MRS worsened (n = 42) | Peri-SS rose a mean of 8.1 points |
Cronbach alpha shows how well the items hang together, and ICC shows whether scores stay steady when the same people answer again. The authors concluded that the Peri-SS is “a reliable, valid, responsive tool for assessing perimenopausal symptom burden.”
What the Peri-SS does not do
The Peri-SS is a symptom questionnaire, so it does not diagnose perimenopause or measure hormones. It tracks self-reported symptom burden over 30 days. In the validation study, stage came from each woman’s own report, and 633 of the 1,255 women identified as perimenopausal.
How it differs from the Menopause Rating Scale
Flo’s release says the MRS “was developed using postmenopausal populations,” and that it omits symptoms such as weight changes, hair loss and digestive issues. Contemporary OB/GYN notes that the MRS was designed for postmenopausal women and paper use. In the validation study, Peri-SS totals correlated with MRS totals at r = 0.88.
Common mix-ups
- The Peri-SS and the in-app “Peri Score.” Flo’s release describes the Peri Score as an in-app feature built on the Peri-SS. It is Flo’s product, so the company’s own description applies to it.
- A symptom total and a stage. The abstract of a 2026 BMJ sexual and reproductive health study says perimenopause “is formally diagnosed by menstrual bleeding patterns.” A symptom total describes how you feel, and bleeding patterns are the marker the abstract names.
- Changed period flow. That same study drew on the Australian Women’s Midlife Years Study, a nationally representative survey of 8,096 women aged 40 to 69. Its flow finding comes from the 1,039 respondents without hot flashes or night sweats. Among them, premenopausal women with changed flow differed little from women with no change in flow. The authors wrote that “change in flow alone is not a clear indicator of commencement of the menopause transition.”
Using a symptom list with your gynecologist
The Cleveland Clinic article on lesser-known symptoms, dated July 14, 2025, says your healthcare provider will want to rule out other health conditions that could be causing your symptoms. It also says that if symptoms affect your quality of life, it’s important to talk to a specialist, “ideally, one who’s specifically trained in menopause medicine.”
A symptom list gives that conversation a starting point. Note which of the 16 areas you’ve noticed, and how often, over the past 30 days. That is the same window the scale uses, so your record lines up with it. For a broader map of the stages, read our menopause stages guide, and to place these symptoms on a timeline, read how long does perimenopause last.
Testosterone’s history in women: the other item in this week’s review
Contemporary OB/GYN’s Contemporary OB/GYN weekly review, published November 16, 2026, also covers the first episode of a Special Report series on testosterone in women. That episode is dated November 13, 2026, and is moderated by Bruce Dorr, MD, and Sharon J. Parish, MD. It’s a clinician conversation in a trade publication.
In the early history of androgen therapy episode, Parish says women were treated with androgens nearly a century ago. She dates the modern story to the 1970s and 1980s, when Helen Singer Kaplan, a Cornell psychiatrist, studied small-dose testosterone implants for women’s desire. No product was approved at the time. Kaplan was especially interested in women moving through perimenopause and menopause.
Parish says the main barrier has been long-term safety data, rather than how well the treatment works. As she puts it: “Early research showed promise for desire, but long-term safety data never caught up.”
Questions to bring to your gynecologist
- Bring: a 30-day record of your symptoms across the four areas of the scale.
- Track: hot flashes, night sweats and any change in your period pattern, since the BMJ abstract names bleeding patterns as the formal marker.
- Ask: whether your symptoms fit perimenopause, and what else should be ruled out first.
- Ask: whether a clinician trained in menopause medicine is the right next step.
- Ask: which tests, if any, they would consider, and what each one would tell you.
By the Integrative Health Evidence Guide Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.